Eloxx
Eloxx is a Massachusetts-based biopharmaceutical company that researches and develops RNA-targeted genetic therapies for the treatment of premature stop codon diseases.
Business Model:
Revenue: $3.6M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Eloxx Information
Geographic Data
Address: 480 Arsenal Way
City: Watertown
State: MA
Zip: 02472
Country: US
Financial Info
Stage:
grant
Raised Last:
$16M
Raised Total:$90M
Social
Metrics
8,173,234Website Global Rank
368Website Monthly Traffic
Twitter Followers
Description
Eloxx is a Massachusetts-based biopharmaceutical company that researches and develops RNA-targeted genetic therapies for the treatment of premature stop codon diseases.
Contact Phone:
+17815775300
Contact Email:
Eloxx went public on 4/26/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/26/2018
Ticker Symbol:
ELOX
IPO Price:
$9.75/share
Amount Raised:
$50M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 4/2021 | Zikani Therapeutics | |
| 6/2017 | Sevion Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
